Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. This makes Cymbalta the second medication ever to be approved for fibromyalgia, following Lyrica’s approval in June 2007.
This is exciting news for fibromyalgia patients. No single medication or treatment is right for everyone, so the mor...
Generic name: Duloxetine Cymbalta is an antidepressant medication. It has been approved for use... Read more »
(Ivanhoe Newswire) -- Women who experience diabetes while they're pregnant are significantly more likely to develop type 2 diabetes following the... Read summary »
(Ivanhoe Newswire) -- Gaining too much weight during pregnancy may be harder on your baby than you think. A new report from the Kaiser Permanente... Read summary »
(Ivanhoe Newswire) -- We may finally know why five-percent of women develop diabetes while they are pregnant. New research from the Stanford... Read summary »
(Ivanhoe Newswire) ? One step to a healthier newborn might be a new toothbrush and some better dental hygiene. The reason: gum disease is linked to a... Read summary »
(Ivanhoe Newswire) -- New research reveals there may be a significant link between depression during pregnancy and preterm delivery. Preterm delivery... Read summary »